Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2001-10-26 (24 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: TREGUNC (29910), Finistere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES PIERRES DEBOUT : revenue, balance sheet and financial ratios
PHARMACIE DES PIERRES DEBOUT is a French company
founded 24 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in TREGUNC (29910),
this company of category PME
shows in 2023 a revenue of 1.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES PIERRES DEBOUT (SIREN 439840166)
Indicator
2024
2023
2021
2020
2019
2017
Revenue
N/C
1 866 910 €
N/C
N/C
N/C
N/C
Net income
36 368 €
17 750 €
67 469 €
58 172 €
67 542 €
55 443 €
EBITDA
N/C
55 725 €
N/C
N/C
N/C
N/C
Net margin
N/C
1.0%
N/C
N/C
N/C
N/C
Revenue and income statement
En 2024, PHARMACIE DES PIERRES DEBOUT genera un resultado neto positivo de 36 k€. Evolución 2017-2024: 55 k€ -> 36 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
36 368 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
El ratio de endeudamiento (= Deuda financiera / Fondos propios x 100) se sitúa en 53%. La deuda permanece bajo control. La autonomía financiera (= Fondos propios / Total activo x 100) alcanza el 59%. Esta alta autonomía significa que la empresa financia la mayoría de sus activos con fondos propios.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
53.121%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
58.644%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES PIERRES DEBOUT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2019
2020
2021
2023
2024
Debt ratio
110.407
90.288
80.591
66.668
63.396
53.121
Financial autonomy
41.77
48.712
50.909
54.575
53.659
58.644
Repayment capacity
None
None
None
None
19.596
None
Cash flow / Revenue
None%
None%
None%
None%
1.596%
None%
Sector positioning
Ratio de endeudamiento
53.122024
2021
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Bueno+5 pts over 3 years
En 2024, el ratio de endeudamiento de PHARMACIE DES PIERRES DEBOUT (53.12) se sitúa por debajo de la mediana del sector. Este ratio mide el peso de la deuda en relación con el patrimonio. Esta posición controlada refleja una gestión prudente.
Autonomía financiera
58.64%2024
2021
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Bueno
En 2024, el autonomía financiera de PHARMACIE DES PIERRES DEBOUT (58.6%) se sitúa por encima de la mediana del sector. Este ratio representa la parte del patrimonio en la financiación total. Esta posición cómoda ofrece un margen de seguridad apreciable.
Capacidad de reembolso
19.6 ans2023
2023
Q1: 0.95 ans
Med: 3.59 ans
Q3: 7.48 ans
Vigilar
En 2023, el capacidad de reembolso de PHARMACIE DES PIERRES DEBOUT (19.6 ans) se sitúa en el top 25% del sector. Este ratio indica el número de años necesarios para pagar la deuda con flujo de caja. Una duración larga puede señalar deuda pesada relativa a la capacidad de pago.
Liquidity ratios
El ratio de liquidez se sitúa en 203.64. La empresa tiene 2€ de activos líquidos por cada 1€ de deuda a corto plazo.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
203.64
Liquidity indicators evolution PHARMACIE DES PIERRES DEBOUT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2019
2020
2021
2023
2024
Liquidity ratio
107.986
202.031
216.83
207.256
189.716
203.64
Interest coverage
None
None
None
None
22.659
None
Sector positioning
Ratio de liquidez
203.642024
2021
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Bueno
En 2024, el ratio de liquidez de PHARMACIE DES PIERRES DEBOUT (203.64) se sitúa por encima de la mediana del sector. Este ratio mide la capacidad de cubrir deuda a corto plazo con activos corrientes. Esta posición cómoda ofrece un margen de seguridad apreciable.
Cobertura de intereses
22.66x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Excelente
En 2023, el cobertura de intereses de PHARMACIE DES PIERRES DEBOUT (22.7x) se sitúa en el top 25% del sector. Este ratio indica cuántas veces el resultado operativo cubre los gastos de intereses. Alta cobertura significa que los gastos financieros pesan poco en la rentabilidad.
Working capital requirement (WCR) and payment terms
El fondo de maniobra operativo (FM) mide el desfase temporal de tesorería.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DES PIERRES DEBOUT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2019
2020
2021
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
243 650 €
0 €
Inventory turnover (days)
0
0
0
0
33
0
Customer payment term (days)
0
0
0
0
4
0
Supplier payment term (days)
0
0
0
0
25
0
Positioning of PHARMACIE DES PIERRES DEBOUT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DES PIERRES DEBOUT is estimated at
507 724 €
(range 353 571€ - 759 584€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
353k€507k€759k€
507 724 €Range: 353 571€ - 759 584€
NAF 5 année 2024
Valuation method used
Net Income Multiple
36 368 €
×
14.0x
=507 724 €
Range: 353 571€ - 759 584€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES PIERRES DEBOUT with other companies in the same sector:
Frequently asked questions about PHARMACIE DES PIERRES DEBOUT
What is the revenue of PHARMACIE DES PIERRES DEBOUT ?
The revenue of PHARMACIE DES PIERRES DEBOUT in 2023 is 1.9 M€.
Is PHARMACIE DES PIERRES DEBOUT profitable?
Yes, PHARMACIE DES PIERRES DEBOUT generated a net profit of 36 k€ in 2024.
Where is the headquarters of PHARMACIE DES PIERRES DEBOUT ?
The headquarters of PHARMACIE DES PIERRES DEBOUT is located in TREGUNC (29910), in the department Finistere.
Where to find the tax return of PHARMACIE DES PIERRES DEBOUT ?
The tax return of PHARMACIE DES PIERRES DEBOUT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES PIERRES DEBOUT operate?
PHARMACIE DES PIERRES DEBOUT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart